Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

Anti–programmed cell death protein 1 (PD-1) therapy provides long-term clinical benefits to patients with advanced melanoma. The composition of the gut microbiota correlates with anti–PD-1 efficacy in preclinical models and cancer patients. To investigate whether resistance to anti–PD-1 can be overc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Science
Main Authors: Davar, Diwakar, Dzutsev, Amiran K., McCulloch, John A., Rodrigues, Richard R., Chauvin, Joe-Marc, Morrison, Robert M., Deblasio, Richelle N., Menna, Carmine, Ding, Quanquan, Pagliano, Ornella, Zidi, Bochra, Zhang, Shuowen, Badger, Jonathan H., Vetizou, Marie, Cole, Alicia M., Fernandes, Miriam R., Prescott, Stephanie, Costa, Raquel G. F., Balaji, Ascharya K., Morgun, Andrey, Vujkovic-Cvijin, Ivan, Wang, Hong, Borhani, Amir A., Schwartz, Marc B., Dubner, Howard M., Ernst, Scarlett J., Rose, Amy, Najjar, Yana G., Belkaid, Yasmine, Kirkwood, John M., Trinchieri, Giorgio, Zarour, Hassane M.
Formato: Artigo
Idioma:Inglês
Publicado: 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8097968/
https://ncbi.nlm.nih.gov/pubmed/33542131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.abf3363
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares